echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JPD: 20 years of follow-up, how have Parkinson's-related psychiatric disorders changed?

    JPD: 20 years of follow-up, how have Parkinson's-related psychiatric disorders changed?

    • Last Update: 2022-04-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by loss of dopaminergic neurons within the substantia nigra accompanied by Lewy body inclusions and α-synapsin deposition
    .


    Parkinson's disease is the second most common neurodegenerative disease after Alzheimer's disease, with an incidence of 14 per 100,000 people, and men are more susceptible than women


    The clinical course of PD is variable and can include motor and nonmotor symptoms
    .


    Among non-motor symptoms, psychosis has a significant clinical impact on PD patients and represents a major challenge in PD treatment


    Quality of Life

    Unfortunately, given the intricate relationship between antiparkinsonian drugs, antipsychotics, and the clinical course of the disease, the treatment of PDP remains a challenge for clinicians
    .


    The use of antipsychotics is the usual initial strategy for the treatment of PDP; however, this treatment has been reported to have relatively poor efficacy and a possible risk of death from cardiovascular disease, especially with typical antipsychotics


    This treatment has relatively poor efficacy and may have a risk of death from cardiovascular disease, especially with typical antipsychotics


    Using the Rochester Epidemiology Project, they studied Parkinson's disease in Olmsted County, Minnesota (1991-2010)
    .


    Movement disorder specialists reviewed electronic medical records and applied diagnostic criteria to PD


    diagnosis

    They identified 669 cases of Parkinson's disease; 297 patients were clinically diagnosed with Parkinson's disease
    .


    114/297 (38.


    The incidence of Parkinson's disease psychosis (PDP) was 4.
    28/100 person-years
    .


    Compared with PD patients, PDP patients had a 71% increased risk of death


    Among Parkinson's disease patients without psychosis, men had a 73.
    4% increased risk of death compared with women, while no significant gender differences were observed between men and women with PDP
    .


    Of the 114 patients diagnosed with psychosis, 59 received antipsychotic medication


    The significance of the study is that it found that, compared with PD patients, PDP increased the odds of death
    .


    Compared with women, men with PD without psychosis had a greater chance of dying; however, among PD patients with psychosis, the odds of death were comparable between men and women
    .
    Finally, treatment with antipsychotics did not significantly affect survival
    .

    PDP increases odds of death compared with PD patients


    Original source:
    Stang CD, Mullan AF, Camerucci E, et al.
    Incidence, Prevalence, and Mortality of Psychosis Associated with Parkinson Disease (1991–2010).

    Incidence, Prevalence, and Mortality of Psychosis Associated with Parkinson Disease (1991–2010).
    Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.